Zobrazeno 1 - 10 of 149 pro vyhledávání: '"Karin Mattson"'
1
Randomized study of vinorelbine–gemcitabine versus vinorelbine–carboplatin in patients with advanced non-small cell lung cancer
Autor: P. Reiterer, Y. Parlier, H. Macha, Rina Hui, M. Wernli, Raymond P. Abratt, J.-P. Burillon, J. von Pawel, Eng Huat Tan, U. Gatzemeier, Karin Mattson, Aleksandra Szczesna, J.C. Pouget, Maciej Krzakowski, Oscar Bertetto
Publikováno v: Lung Cancer. 49:233-240
The objective of this trial was to compare two vinorelbine-based doublets with carboplatin (CBDCA-VC) or with gemcitabine (VG) in patients with stage IIIB-IV non-small cell lung cancer (NSCLC).A total of 316 patients with advanced NSCLC previously un
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb34df8940351e95f7edbb6b881d3ed
https://doi.org/10.1016/j.lungcan.2005.03.029
Zobrazit plný text záznamu
2
Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer
Autor: Reijo Salovaara, Jarmo A. Salo, Jaakko Hollmén, Harriet Wikman, Antti Karjalainen, Sisko Anttila, Irmeli Lindström, Eeva Kettunen, Henrik Edgren, Anna-Maria Nissén, Karin Mattson, Jouni K. Seppänen, Sakari Knuutila
Publikováno v: Cancer Genetics and Cytogenetics. 149:98-106
The expression patterns of cancer-related genes in 13 cases of squamous cell lung cancer (SCC) were characterized and compared with those in normal lung tissue and 13 adenocarcinomas (AC), the other major type of nonsmall cell lung cancer (NSCLC). cD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f892a0297cbba90b789ce8a0a4570548
https://doi.org/10.1016/s0165-4608(03)00300-5
Zobrazit plný text záznamu
3
Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy
Autor: Tarja Ruotsalainen, Heikki Joensuu, Sirpa Leppä, Karin Mattson, Anu Anttonen, Henrik Alfthan
Publikováno v: Lung Cancer. 41:171-177
Syndecan-1 is a multifunctional transmembrane heparan sulphate proteoglycan (HSPG) that is present on a variety of cell types. The extracellular syndecan domains can be shed from the cell surface in a highly regulated process called ectodomain sheddi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e441697b0da2de27877aade9bd04ed4
https://doi.org/10.1016/s0169-5002(03)00196-x
Zobrazit plný text záznamu
4
ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study
Autor: Stephen Clarke, Pieter E. Postmus, Christian Manegold, Karin Mattson, Egbert F. Smit, J. von Pawel
Publikováno v: Smit, E F, Mattson, K, van Pawel, J, Manegold, C, Clarke, S & Postmus, P E 2003, ' ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study. ', Annals of Oncology, vol. 14, no. 3, pp. 455-60 . https://doi.org/10.1093/annonc/mdg099
Annals of Oncology, 14(3), 455-60. Oxford University Press
Background The purpose of this study was to evaluate ALIMTA® (pemetrexed disodium, LY231514), a multi-targeted antifolate with first-line activity against non-small-cell lung cancer (NSCLC), in a second-line setting. Patients and methods Patients wi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd682df1bf8ec36ef490abb67339585
https://hdl.handle.net/1871/26338
Zobrazit plný text záznamu
5
Evaluation of pleural disease using MR and CT: With special reference to malignant pleural mesothelioma
Autor: M. Palomäki, A. Kivisaari, Karin Mattson, Pekka Tervahartiala, Leena Kivisaari, Aija Knuuttila
Publikováno v: Acta Radiologica. 42:502-507
Purpose: To evaluate MR imaging and CT in differentiating malignant pleural mesothelioma from other malignancies or benign pleural disease. Material and Methods: Thirty-four patients (18 pleural mesotheliomas, 9 other malignancies, 7 benign pleural d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::101fa07d83fc63f60b76097a948b0643
https://doi.org/10.1080/028418501127347070
Zobrazit plný text záznamu
6
Pulmonary Infection Caused by an Unusual, Slowly Growing Nontuberculous Mycobacterium
Autor: Eljas Brander, Marja-Leena Katila, Lars Paulin, Sini Suomalainen, Karin Mattson, Pirkko Koukila-Kähkölä, Anneli Piilonen
Publikováno v: Journal of Clinical Microbiology. 39:2668-2671
Mycobacterium triplex , a recently described slowly growing nontuberculous mycobacterium, was isolated from a Finnish patient with pulmonary mycobacteriosis. The disease was successfully treated with antimycobacterial drugs. The strain isolated, whic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a3b6e9e562b4462e5ddab0ab29e174
https://doi.org/10.1128/jcm.39.7.2668-2671.2001
Zobrazit plný text záznamu
8
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Autor: Mark Vincent, Frances A. Shepherd, Nathan Levitan, Ronald L. Burkes, Laurent Gressot, Mark Allen O'Rourke, Jocelyne Berille, Rodryg Ramlau, Karin Mattson, Richard J. Gralla, Janet Dancey, Susan Coughlin, Yong Kim
Publikováno v: Journal of Clinical Oncology. 18:2095-2103
PURPOSE To evaluate whether treatment with single-agent docetaxel would result in longer survival than would best supportive care in patients with non–small-cell lung cancer who had previously been treated with platinum-based chemotherapy. Secondar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8c319eee13f865630b68440f444f58e
https://doi.org/10.1200/jco.2000.18.10.2095
Zobrazit plný text záznamu
9
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma - a feasibility study
Autor: Leena Kivisaari, Maija Halme, Tiina Ollikainen, Aija Knuuttila, Pekka Mali, Karin Mattson, Kaija Linnainmaa, Antti Jekunen
Publikováno v: Anti-Cancer Drugs. 11:257-261
We chose to treat malignant pleural mesothelioma with a combination of docetaxel and irinotecan (CPT-11), because there have been preliminary reports that CPT-11 is active against mesothelioma, and docetaxel and CPT-11 were the most active agents in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ef3e43782594138c62234585a1628d
https://doi.org/10.1097/00001813-200004000-00005
Zobrazit plný text záznamu
10
A Broad Amplification Pattern at 3q in Squamous Cell Lung Cancer—A Fluorescence In Situ Hybridization Study
Autor: Karin Mattson, Sisko Anttila, Antti Karjalainen, Eeva Kettunen, Sakari Knuutila, Kirsti Husgafvel-Pursiainen, Henrik Wolff, Anna Maria Björkqvist, Wael El-Rifai
Publikováno v: Cancer Genetics and Cytogenetics. 117:66-70
Frequent DNA copy number gain at 3q, with minimal overlapping area at 3q24-qter, has previously been reported in squamous cell carcinoma of the lung (SQCC), implicating the importance of genes at 3q in the tumorigenesis of SQCC. To further characteri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::118ff8862f9a213f961a67e85422fdf3
https://doi.org/10.1016/s0165-4608(99)00146-6
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje